19788-37-5 Usage
Description
4-(Chloromethyl)-3,5-dimethylisoxazole is an organic compound that participates in asymmetric isoxazole annulation reactions. It is a colorless to yellow liquid and is utilized in the synthesis of various chemical compounds.
Uses
Used in Chemical Synthesis:
4-(Chloromethyl)-3,5-dimethylisoxazole is used as a key intermediate in the synthesis of complex organic molecules, particularly in the preparation of:
4(3-oxoalkyl)isoxazole: 4-(CHLOROMETHYL)-3,5-DIMETHYLISOXAZOLE is synthesized using 4-(Chloromethyl)-3,5-dimethylisoxazole as a starting material, which can be further utilized in various chemical applications.
(E)-3,5-dimethyl-4-(2-(thiophene-3-yl)vinyl)isoxazole: 4-(CHLOROMETHYL)-3,5-DIMETHYLISOXAZOLE is another product derived from 4-(Chloromethyl)-3,5-dimethylisoxazole, which can be used in the development of pharmaceuticals, agrochemicals, or other specialty chemicals.
The specific application reasons for these synthesized compounds may vary depending on their properties and the requirements of the industries they are used in.
Check Digit Verification of cas no
The CAS Registry Mumber 19788-37-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,8 and 8 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19788-37:
(7*1)+(6*9)+(5*7)+(4*8)+(3*8)+(2*3)+(1*7)=165
165 % 10 = 5
So 19788-37-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H8ClNO/c1-4-6(3-7)5(2)9-8-4/h3H2,1-2H3
19788-37-5Relevant articles and documents
NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE AS PPAR-ALPHA MODULATORS
-
Page/Page column 70, (2010/10/20)
The invention relates to novel pyrimidine derivatives of general formula (I), methods for the production thereof, their use for treating and/or preventing diseases, and to their use for producing medicaments for treating and/or preventing diseases, preferably for treating and/or preventing cardiovascular diseases, particularly dyslipidemia, arteriosclerosis, insufficiency of the heart, thrombosis and metabolic syndrome.
New triazole antifungal agents derived from mercaptomethylisoxazoles
Moreno-Manas,Arredondo,Pleixats,Teixido,Raga,Palacin,Castello,Ortiz
, p. 1557 - 1560 (2007/10/02)
-
PHARMACOLOGICALLY ACTIVE THIOUREA AND UREA COMPOUNDS
-
, (2008/06/13)
The compounds are substituted thioalkyl-, aminoalkyl-and oxyalkyl-thioureas and ureas which are inhibitors of histamine activity.